{"issuance_frequency":"","notes_translated":{"fr":"Santé Canada publie cet avis à l'intention des promoteurs d'essais cliniques afin de clarifier leurs principales obligations en fonction des exigences du Règlement sur les aliments et drogues (RAD) en ce qui a trait aux divers types de recherche clinique sur le cannabis.","en":"Health Canada is issuing this notice to clinical trial sponsors to clarify key obligations under the Food and Drug Regulations (FDR) for various types of cannabis-based clinical research."},"issn":"","imso_approval":"true","isbn":"","creator":"","org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"edition":"","frequency":"as_needed","data_series_issue_identification":{"fr":"","en":""},"contributor":{"fr":"","en":""},"maintainer":null,"ready_to_publish":"true","id":"e4f8e3f2-12e7-4fbb-9f34-36849f6c2982","metadata_created":"2021-06-01T18:01:47.836255","subject":["health_and_safety"],"pspc_identification_number":"","metadata_modified":"2021-06-01T18:01:47.836261","author":null,"author_email":null,"geographic_region":[],"portal_release_date":"2021-06-01","digital_object_identifier":"","state":"active","version":null,"keywords":{"fr":["avis aux intervenants","clarification des exigences","Règlement sur les aliments et drogues","essai clinique","recherche clinique","cannabis"],"en":["notice to stakeholders","clarification of requirements","Food and Drug Regulations","clinical trial","clinical research","cannabis"]},"relationships_as_object":[],"creator_user_id":"2dc5a12f-2a6f-4822-8514-165ea6bb05d9","title_translated":{"fr":"Avis aux intervenants – Clarification des exigences prévues par le Règlement sur les aliments et drogues lors de la conduite de recherches cliniques sur le cannabis","en":"Notice to Stakeholders – Clarification of Requirements Under the Food and Drug Regulations When Conducting Clinical Research With Cannabis"},"type":"info","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"e4f8e3f2-12e7-4fbb-9f34-36849f6c2982","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"44e63009-3150-4712-885b-1024753f4a72","related_relationship":"","name_translated":{"fr":"Avis aux intervenants – Clarification des exigences prévues par le Règlement sur les aliments et drogues lors de la conduite de recherches cliniques sur le cannabis","en":"Notice to Stakeholders – Clarification of Requirements Under the Food and Drug Regulations When Conducting Clinical Research With Cannabis"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Notice to Stakeholders – Clarification of Requirements Under the Food and Drug Regulations When Conducting Clinical Research With Cannabis","language":["en"],"created":"2021-06-01T18:01:47.961015","url":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/announcements/notice-clarification-requirements-conducting-clinical-research-cannabis.html","last_modified":null,"position":0,"revision_id":"3160b119-c7de-43c3-b829-df6afa6c6b9d","resource_type":"publication"},{"cache_last_updated":null,"unique_identifier":"","package_id":"e4f8e3f2-12e7-4fbb-9f34-36849f6c2982","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"8c6aa0d0-018f-4498-9016-df55f63b0a24","related_relationship":"","name_translated":{"fr":"Avis aux intervenants – Clarification des exigences prévues par le Règlement sur les aliments et drogues lors de la conduite de recherches cliniques sur le cannabis","en":"Notice to Stakeholders – Clarification of Requirements Under the Food and Drug Regulations When Conducting Clinical Research With Cannabis"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Notice to Stakeholders – Clarification of Requirements Under the Food and Drug Regulations When Conducting Clinical Research With Cannabis","language":["fr"],"created":"2021-06-01T18:01:47.961020","url":"https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/annonces/avis-clarification-exigences-conduite-recherches-cliniques-cannabis.html","last_modified":null,"position":1,"revision_id":"3160b119-c7de-43c3-b829-df6afa6c6b9d","resource_type":"publication"}],"place_of_publication":[],"num_resources":2,"tags":[],"spatial":"","collection":"publication","org_title_at_publication":{"fr":"Santé Canada","en":"Health Canada"},"date_published":"2021-02-05 00:00:00","issuance":"","groups":[],"license_id":"ca-ogl-lgo","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:33.001625","title":"Health Canada | Santé Canada","name":"hc-sc","is_organization":true,"state":"active","image_url":"","revision_id":"6a0471e8-36e5-4217-8f72-563c83e6465a","type":"organization","id":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","approval_status":"approved"},"name":"e4f8e3f2-12e7-4fbb-9f34-36849f6c2982","isopen":false,"additional_notes":{"fr":"","en":""},"departmental_identification_number":"","notes":"Health Canada is issuing this notice to clinical trial sponsors to clarify key obligations under the Food and Drug Regulations (FDR) for various types of cannabis-based clinical research.","owner_org":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","program_page_url":{"fr":"","en":""},"url":null,"audience":[],"gc_catalogue_number":"","license_url":"http://open.canada.ca/en/open-government-licence-canada","series_publication_dates":{"fr":"","en":""},"title":"Notice to Stakeholders – Clarification of Requirements Under the Food and Drug Regulations When Conducting Clinical Research With Cannabis","revision_id":"3160b119-c7de-43c3-b829-df6afa6c6b9d"}